JP2020504722A5 - - Google Patents

Download PDF

Info

Publication number
JP2020504722A5
JP2020504722A5 JP2019533084A JP2019533084A JP2020504722A5 JP 2020504722 A5 JP2020504722 A5 JP 2020504722A5 JP 2019533084 A JP2019533084 A JP 2019533084A JP 2019533084 A JP2019533084 A JP 2019533084A JP 2020504722 A5 JP2020504722 A5 JP 2020504722A5
Authority
JP
Japan
Prior art keywords
subject
increase
agent according
drug
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019533084A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020504722A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2017/051435 external-priority patent/WO2018112541A1/en
Publication of JP2020504722A publication Critical patent/JP2020504722A/ja
Publication of JP2020504722A5 publication Critical patent/JP2020504722A5/ja
Pending legal-status Critical Current

Links

JP2019533084A 2016-12-21 2017-12-21 血管密度を増加させる方法 Pending JP2020504722A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2016905310A AU2016905310A0 (en) 2016-12-21 Methods for enhancing vascular density
AU2016905310 2016-12-21
PCT/AU2017/051435 WO2018112541A1 (en) 2016-12-21 2017-12-21 Methods for enhancing vascular density

Publications (2)

Publication Number Publication Date
JP2020504722A JP2020504722A (ja) 2020-02-13
JP2020504722A5 true JP2020504722A5 (cg-RX-API-DMAC7.html) 2021-02-04

Family

ID=62624132

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019533084A Pending JP2020504722A (ja) 2016-12-21 2017-12-21 血管密度を増加させる方法

Country Status (8)

Country Link
US (2) US20190328761A1 (cg-RX-API-DMAC7.html)
EP (1) EP3558312A4 (cg-RX-API-DMAC7.html)
JP (1) JP2020504722A (cg-RX-API-DMAC7.html)
KR (1) KR20190110547A (cg-RX-API-DMAC7.html)
CN (2) CN116509885A (cg-RX-API-DMAC7.html)
AU (1) AU2017383100B2 (cg-RX-API-DMAC7.html)
CA (1) CA3047437A1 (cg-RX-API-DMAC7.html)
WO (1) WO2018112541A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102354784B1 (ko) 2015-08-05 2022-01-25 메트로 인터내셔널 바이오테크 엘엘씨 니코틴아미드 모노뉴클레오티드 유도체 및 그 용도
GB2542881B (en) 2015-10-02 2020-01-01 Carr Andrew Crystal forms of ß-nicotinamide mononucleotide
CN109674808A (zh) * 2019-01-30 2019-04-26 四川大学 β-烟酰胺单核苷酸或其前体在制备延缓肺衰老药物中的用途
CN110638826A (zh) * 2019-10-09 2020-01-03 泓博元生命科技(深圳)有限公司 Nadh和/或nmn在制备肌肉增强或抑制肌肉量下降的药物或保健品中的应用
CN110734950A (zh) * 2019-11-14 2020-01-31 南方医科大学珠江医院 一种nmn治疗与改善cmva的相关性的体外实验法
CN110974781A (zh) * 2020-01-02 2020-04-10 崔立峰 一种用于皮肤创面修复的凝胶
WO2021183779A1 (en) * 2020-03-11 2021-09-16 Massachusetts Eye And Ear Infirmary Gene therapy for nmnat1-associated retinal degeneration
EP4070799A1 (en) * 2021-04-08 2022-10-12 Nuvamid SA Compositions for the improvement of sport performance
CN116981482B (zh) * 2022-02-28 2024-08-09 深圳大学 使klf4去乙酰化以促进其转录活性的作用剂的用途、维持肺动脉内皮细胞功能的方法和治疗肺动脉高压的方法
CN115227712A (zh) * 2022-07-26 2022-10-25 上海市第五人民医院 NaHS在制备治疗骨质疏松药物中的应用
CN121152567A (zh) 2023-05-12 2025-12-16 明治控股股份有限公司 用于促进儿童的发育的组合物
JP7555159B1 (ja) * 2023-06-29 2024-09-24 株式会社レースホース 動物用栄養組成物
CN117771375A (zh) * 2024-01-31 2024-03-29 中山大学附属第三医院 SIRT1/PGC-1α通路激活剂的新用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1964627B (zh) * 2004-06-04 2011-10-19 华盛顿大学 治疗神经病变的方法和组合物
WO2006094235A1 (en) * 2005-03-03 2006-09-08 Sirtris Pharmaceuticals, Inc. Fused heterocyclic compounds and their use as sirtuin modulators
US7855289B2 (en) * 2005-08-04 2010-12-21 Sirtris Pharmaceuticals, Inc. Sirtuin modulating compounds
CN102985553B (zh) * 2010-04-15 2015-11-25 西特里斯药业公司 沉默调节蛋白活化剂和活化测定
US20140065099A1 (en) * 2011-02-15 2014-03-06 Ecole Polytechnique Federale De Lausanne (Epfl) Methods of Treating Mitochondrial Dysfunction
WO2013002879A1 (en) * 2011-06-29 2013-01-03 President And Fellows Of Harvard College Small molecule cd38 inhibitors and methods of using same
US9877981B2 (en) * 2012-10-09 2018-01-30 President And Fellows Of Harvard College NAD biosynthesis and precursors for the treatment and prevention of cancer and proliferation
EP3151671A4 (en) * 2014-06-03 2018-03-07 Sulfagenix, Inc. Methods and compositions for treating nitric oxide deficiency disorders and related conditions
US10653782B2 (en) * 2014-11-25 2020-05-19 Nortwestern University Retroviral particles expressing Sirt1 embedded within PPCN

Similar Documents

Publication Publication Date Title
JP2020504722A5 (cg-RX-API-DMAC7.html)
Romero-Arenas et al. Impact of resistance circuit training on neuromuscular, cardiorespiratory and body composition adaptations in the elderly
Clayton Core training and rehabilitation in horses
Mahdiabadi et al. The effect of aerobic continuous and interval training on left ventricular structure and function in male non-athletes
Caldwell Exercise in the elderly: An overview
Karpov et al. Physiologically Based Approaches to the Rehabilitation of Scoliosis.
Misra et al. Effect of balloon-blowing exercise on oxygen saturation in COVID-19 patients
JP2014520854A5 (cg-RX-API-DMAC7.html)
CN209048988U (zh) 一种医用心血管病恢复锻炼装置
Bahramian et al. The effects of exercise training intensity on the expression of C/EBPβ and CITED4 in rats with myocardial infarction
RU2487694C1 (ru) Способ ранней реабилитации в остром периоде инсульта в условиях отделения реанимации и интенсивной терапии
RU2018115152A (ru) Способ преабилитации пациентов с ишемической болезнью сердца перед коронарным шунтированием в условиях искусственного кровообращения
Morán et al. Exercise-induced pulmonary haemorrhage in horses–review
CN104349786B (zh) 骨骼肌慢肌化剂
Angelopoulos et al. Blood Flow Restriction Training in
Haykowsky et al. Heart transplant recipient finishes the 118th Boston Marathon 27 years post-surgery
Ciortea et al. A current challenge of rehabilitation medicine: The management of disabilities induced by acute SARS-CoV-2 infection
KR101942205B1 (ko) 무력증 및/또는 만성 피로 증후군의 증상을 교정하거나 치료하기 위한 약학 조성물
RU2780129C2 (ru) Способ мобилизации активности человека, обусловленной его природными, эволюционными возможностями
Parlak Exercise in special conditions
Vakhitov et al. “Negative phase” of the heart rate and stroke volume in young athletes after the Harvard step test
SU1174025A1 (ru) Способ лечени бронхиальной астмы у детей 7-13 лет
Navazio et al. Benefits of physical exercise
Odendaal Muscle magic & feeding
Li et al. B A multi-OMICS approach to generate novel mechanistic insights and new targets for cardiovascular regeneration in the ischaemic adult heart